Specifically using MSP, they looked at methylation of CDKN2A, MGMT, DAPK and GSTP1, genes whose aberrant methylation profiles have already been shown to associate with lung cancer risk or diagnosis [66]. This evidence concerns the gene CDKN2A and lung carcinoma.